ImmunityBio (IBRX) is up 25.3%, or $1.40 to $6.92.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IBRX:
- Morning Movers: Fastenal and 3M slip following quarterly results
- Video: Stocks point lower as Greenland tensions reach boiling point
- ImmunityBio: Accelerating ANKTIVA Commercial Traction and Global Regulatory Momentum Support Buy Rating
- ImmunityBio price target raised to $7 from $5 at Piper Sandler
- ImmunityBio provides update on Type B meeting with FDA on Anktiva pathway